Astrid Borkowski

4.9k total citations
50 papers, 2.7k citations indexed

About

Astrid Borkowski is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Astrid Borkowski has authored 50 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 24 papers in Epidemiology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Astrid Borkowski's work include Viral gastroenteritis research and epidemiology (16 papers), Influenza Virus Research Studies (15 papers) and Respiratory viral infections research (15 papers). Astrid Borkowski is often cited by papers focused on Viral gastroenteritis research and epidemiology (16 papers), Influenza Virus Research Studies (15 papers) and Respiratory viral infections research (15 papers). Astrid Borkowski collaborates with scholars based in Switzerland, United States and Germany. Astrid Borkowski's co-authors include Aino Karvonen, Nicola Groth, Geert Leroux‐Roels, Ralf Clemens, Timo Vesikari, Frédéric Clément, Paul M. Mendelman, Thomas Vanwolleghem, Jeanne‐Marie Devaster and Mamadou Dramé and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Astrid Borkowski

50 papers receiving 2.6k citations

Peers

Countries citing papers authored by Astrid Borkowski

Since Specialization

Citations

This map shows the geographic impact of Astrid Borkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Borkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Borkowski more than expected).

Fields of papers citing papers by Astrid Borkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Borkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Borkowski. The network helps show where Astrid Borkowski may publish in the future.

Co-authorship network of co-authors of Astrid Borkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Borkowski. A scholar is included among the top collaborators of Astrid Borkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Borkowski. Astrid Borkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidemiology of norovirus disease in the first 2 years of life: A prospective multisite cohort study in Lima, Peru 2024 ·International Journal of Infectious Diseases ·Claudio F. Lanata, Giselle Soto, Ana M. Gil, (unknown), (unknown), Candice Romero, Lucie Ecker, (unknown), (unknown), Ana Goios, Astrid Borkowski, J Weil	2
2	Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study 2023 ·PLoS neglected tropical diseases ·Vianney Tricou, Brandon Essink, John Ervin, M. Turner, Ian Escudero, Martina Rauscher, Manja Brose, Inge Lefevre, Astrid Borkowski, Derek Wallace	16
3	Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study 2022 ·Vaccine ·Timo Vesikari, Xavier Sáez‐Llorens, Vesna Blazevic, Pío López, (unknown), (unknown), Paul M. Mendelman, Mengya Liu, James Sherwood, Frank Baehner, Astrid Borkowski	18
4	Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial 2021 ·The Lancet Infectious Diseases ·(unknown), Clemente Díaz, Camilo J. Acosta, Mengya Liu, Astrid Borkowski	36
5	A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose 2020 ·Vaccine ·John Treanor, (unknown), Jakob P. Cramer, (unknown), (unknown), Frank Baehner, Astrid Borkowski	26
6	Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study 2017 ·The Lancet Infectious Diseases ·Xavier Sáez‐Llorens, Vianney Tricou, Delia Yu, Luis Rivera, José Jimeno, (unknown), (unknown), (unknown), Maria Vargas, Manja Brose, Martina Rauscher, Suely Tuboi, Astrid Borkowski, Derek Wallace	58
7	Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study 2017 ·The Lancet Infectious Diseases ·Xavier Sáez‐Llorens, Vianney Tricou, Delia Yu, Luis Rivera, Suely Tuboi, (unknown), Astrid Borkowski, Derek Wallace	66
8	Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial 2016 ·The Journal of Infectious Diseases ·Robert L. Atmar, Frank Baehner, Jakob P. Cramer, Eric Song, Astrid Borkowski, Paul M. Mendelman	50
9	Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children 2011 ·New England Journal of Medicine ·Timo Vesikari, Markus Knuf, Peter Wutzler, Aino Karvonen, Dorothee Kieninger‐Baum, Heinz‐Josef Schmitt, Frank Baehner, Astrid Borkowski, Theodore F. Tsai, Ralf Clemens	230
10	Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly 2011 ·Vaccine ·Timo Vesikari, Aino Forstén, Karl–Heinz Herbinger, Giovanni Della Cioppa, (unknown), Astrid Borkowski, Nicola Groth, (unknown), Frank von Sonnenburg	49
11	Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine 2011 ·The Pediatric Infectious Disease Journal ·(unknown), Matthew D. Snape, Dominic F. Kelly, (unknown), Susan J. Lewis, Linda Diggle, Tessa M. John, Ly‐Mee Yu, Omar Omar, Astrid Borkowski, Andrew J. Pollard	10
12	Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial 2009 ·Vaccine ·Wendy A. Keitel, Nicola Groth, Maria Lattanzi, Michaela Praus, Anne Katrin Hilbert, Astrid Borkowski, (unknown)	61
13	MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination 2009 ·Vaccine ·Timo Vesikari, Nicola Groth, Aino Karvonen, Astrid Borkowski, Michele Pellegrini	115
14	Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant 2009 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Michele Pellegrini, Aino Karvonen, Nicola Groth, Astrid Borkowski, Derek T. O’Hagan, Audino Podda	155
15	Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study 2008 ·BMJ ·Matthew D. Snape, Dominic F. Kelly, Steff Lewis, (unknown), (unknown), Catrin E. Moore, Linda Diggle, Tessa M. John, Ly‐Mee Yu, Ray Borrow, Astrid Borkowski, Carla Nau, Andrew J. Pollard	91
16	Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial 2007 ·The Lancet ·Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem, Mamadou Dramé, Frédéric Clément, (unknown), Jeanne‐Marie Devaster, Geert Leroux‐Roels	414
17	Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients 2005 ·Vaccine ·(unknown), A Marx, Olaf Burkhardt, Brunhilde Schweiger, Astrid Borkowski, Angelika Banzhoff, Mathias W. Pletz, H. Lode	41
18	Prepregnancy Testing for Single-Gene Disorders by Polar Body Analysis 1999 ·Genetic Testing ·Yury Verlinsky, Svetlana Rechitsky, Oleg Verlinsky, (unknown), Aaron Lifchez, B. Kaplan, J. Moise, J. Valle, Astrid Borkowski, (unknown), (unknown), C. Ström, Anver Kuliev	30
19	Analysis of VH-D-JH gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sj�gren's syndrome 1999 ·Arthritis & Rheumatism ·Sylke Gellrich, Sascha Rutz, Astrid Borkowski, (unknown), Erika Gromnica‐Ihle, Wolfram Sterry, (unknown)	50
20	Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH 1998 ·The Prostate ·Franklin C. Lowe, K. Dreikorn, Astrid Borkowski, Johan Braeckman, L. Denis, Paolo Ferrari, Glenn S. Gerber, Robert M. Levin, Paul B. Perrin, Theodor Senge	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact